Preventing severe mental illnesses - New prospects and ethical challenges

Schizophrenia Research

Volumn 51, Issue 1, 2001, Pages 3-15

  Schaffner, Kenneth F ^a   McGorry, Patrick D ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical trials; Early intervention; Early psychosis; Ethics; Policy; Prodrome; Schizophrenia

Indexed keywords

CASE FINDING; DIAGNOSTIC APPROACH ROUTE; ETHICS; HUMAN; MENTAL DISEASE; PATIENT CODING; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME; TYPES OF STUDY;

EID: 0035424138     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00234-1     Document Type: Article

References (46)

1. False hopes and best data: Consent to research and the therapeutic misconception
2. Early intervention and sustaining the management of vulnerability
3. Decisional capacity for informed consent in schizophrenia research
4. The number needed to treat: A clinically useful measure of treatment effect
5. Treatment of the schizophrenia prodrome: Is it presently ethical?
6. Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia
7. Equipoise and the ethics of clinical research
8. Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia
9. Report on the November 2000 NIMH informed consent in early intervention is psychosis workshop
10. Untreated initial psychosis: Its relation to quality of life and symptom remission in first-episode schizophrenia
11. Early detection strategies for untreated first psychosis
12. Diagnosing schizophrenia in the initial prodromal phase
13. Recent Dutch developments of research guidelines on psychiatric subjects
14. Delayed detection of psychosis: Causes, consequences, and effect on public health
15. Psychotic disorders in adolescents and young adults: Earl intervention, follow-up results and ethical implications
16. International clinical trials with applicability to mentally impaired individuals: The conundrum of third world sites
17. Psychosis treatment prior to psychosis onset: Ethical issues
18. Schizophrenia: Risk and possibility
19. Spurious precision: Procedural validity of diagnostic assessment in psychotic disorders
20. The early psychosis prevention and intervention centre (EPPIC): An evolving system of early detection and optimal management
21. Early detection and treatment delay: Implications for outcome in early psychosis
22. A randomised controlled trial of interventions in the pre-psychotic phase of psychotic disorders
23. Recognition and treatment of the pre-psychotic phase of psychotic disorders: Frontier or fantasy?
24. Closing in: What features predict the onset of first episode psychosis within an ultra high risk group?
25. Ethics and early intervention in psychosis: Keeping up the pace and staying in step
26. Identification of young people at risk of psychosis: Validation of personal assessment and crisis evaluation clinic intake criteria
27. Prevention of Alzheimer disease and prevention of schizophrenia: Some comparative comments
28. Competency: A triaxial concept
29. Do causes count: Lessons for behavioral psychogenetics from Alzheimer's disease research
30. Toward reformulating the diagnosis of schizophrenia
31. Strauss 1969 revisited: A psychosis continuum in the general population?
32. Novel early interventions for prodromal states
33. Neuroleptics and the natural course of schizophrenia
34. Rationale for the study of early intervention
35. Initial prodrome in psychosis: Descriptive and qualitative aspects
36. Monitoring and care of young people at incipient risk of psychosis
37. Prediction of psychosis